SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-14-001951
Filing Date
2014-03-07
Accepted
2014-03-07 11:04:20
Documents
10
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F a2217900z20-f.htm 20-F 7842258
2 EX 1.1 a2217900zex-1_1.htm EX-1.1 112588
3 EX 1.2 a2217900zex-1_2.htm EX-1.2 66957
4 EX 12.1 a2217900zex-12_1.htm EX-12.1 12603
5 EX 12.2 a2217900zex-12_2.htm EX-12.2 12626
6 EX 13.1 a2217900zex-13_1.htm EX-13.1 5557
7 EX 13.2 a2217900zex-13_2.htm EX-13.2 6178
8 EX 23.1 a2217900zex-23_1.htm EX-23.1 2908
9 EX 23.2 a2217900zex-23_2.htm EX-23.2 3263
10 EX 99.1 a2217900zex-99_1.htm EX-99.1 66966
  Complete submission text file 0001047469-14-001951.txt   8133035
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-31368 | Film No.: 14675682
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences